Endocrinology clinics are advancing the integration of continuous glucose monitoring (CGM) data from multiple vendors into electronic health records (EHRs) to strengthen diabetes management.

Researchers conducted a retrospective cross-sectional analysis of patients diagnosed with de novo metastatic breast cancer to evaluate presentation and treatment differences across three main subtypes ...

Explore Tesamorelin, a synthetic GHRH analog shaping research on growth hormone regulation, lipid metabolism, IGF-1 signaling ...

Palazestrant’s mechanism of action confirmed; full recruitment of corepressor protein NCoR1 enables complete antagonism of the estrogen ...

Peptide-based signaling systems occupy a central position in modern biochemical inquiry due to their potential to interface ...

Learning human anatomy can feel overwhelming, but with the right tools and strategies, you can master it efficiently. From interactive 3D models to systematic study frameworks, today’s resources make ...

Emerging research has raised fresh concerns about the impact of microplastics and nanoplastics on human health, particularly ...

Department of Health – Abu Dhabi introduces daily oral obesity treatment ...

Results showed lasofoxifene protected against hormone withdrawal-induced bone loss and maintained a robust anti-tumor response in primary and metastatic animal models of ER+ breast cancerBOTHELL, Wash ...

Key opportunities in the rare disease clinical trials market include expanding orphan drug programs, adopting virtual/hybrid ...

Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...